Immunovant, Inc. (IMVT) Social Stream
IMMUNOVANT INC (IMVT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IMMUNOVANT INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-22 | 8 | $22 | $10 | $14 | $42.87 | -67.34% |
| 2022-01-05 | 8 | $22 | $9 | $13.285 | $42.87 | -69.01% |
| 2022-02-07 | 8 | $20 | $9 | $13 | $42.87 | -69.68% |
| 2022-03-29 | 8 | $20.001 | $9 | $13 | $42.87 | -69.68% |
| 2022-04-12 | 7 | $16 | $9 | $12.142 | $42.87 | -71.68% |
| 2022-06-09 | 8 | $16 | $9 | $12.142 | $42.87 | -71.68% |
| 2022-09-07 | 7 | $16 | $9 | $12.5 | $42.87 | -70.84% |
| 2022-09-26 | 8 | $16 | $5.001 | $11.428 | $42.87 | -73.34% |
| 2022-09-29 | 8 | $16 | $5.001 | $11.143 | $42.87 | -74.01% |
| 2022-11-08 | 8 | $19 | $5.001 | $12.714 | $42.87 | -70.34% |
| 2022-11-15 | 8 | $30 | $5.001 | $15.285 | $42.87 | -64.35% |
| 2022-12-13 | 8 | $30 | $5.001 | $17.857 | $42.87 | -58.35% |
| 2023-01-03 | 8 | $30 | $5.001 | $20.285 | $42.87 | -52.68% |
| 2023-02-06 | 8 | $31 | $5.001 | $21.428 | $42.87 | -50.02% |
| 2023-02-08 | 9 | $31 | $5.001 | $22.285 | $42.87 | -48.02% |
| 2023-02-13 | 9 | $31 | $5.001 | $23.25 | $42.87 | -45.77% |
| 2023-02-15 | 10 | $31 | $5.001 | $24 | $42.87 | -44.02% |
| 2023-03-20 | 10 | $31 | $5.001 | $24.555 | $42.87 | -42.72% |
| 2023-03-29 | 12 | $31 | $5.001 | $24.9 | $42.87 | -41.92% |
| 2023-04-04 | 12 | $31 | $5.001 | $25.181 | $42.87 | -41.26% |
| 2023-04-25 | 14 | $31 | $5.001 | $25.416 | $42.87 | -40.71% |
| 2023-05-23 | 14 | $32 | $5.001 | $27.077 | $42.87 | -36.84% |
| 2023-06-09 | 14 | $32 | $5.001 | $27.23 | $42.87 | -36.48% |
| 2023-07-05 | 14 | $32 | $5.001 | $26.833 | $42.87 | -37.41% |
| 2023-07-17 | 14 | $32 | $5.001 | $26.916 | $42.87 | -37.21% |
| 2023-07-18 | 14 | $35 | $5.001 | $27.833 | $42.87 | -35.08% |
| 2023-08-11 | 14 | $34 | $5.001 | $28.416 | $42.87 | -33.72% |
| 2023-08-15 | 13 | $34 | $5.001 | $28.833 | $42.87 | -32.74% |
| 2023-09-27 | 13 | $40 | $18 | $30.785 | $42.87 | -28.19% |
| 2023-10-16 | 13 | $55 | $28 | $43 | $42.87 | 0.3% |
| 2023-10-25 | 13 | $57 | $30 | $46.357 | $42.87 | 8.13% |
| 2023-11-09 | 13 | $57 | $30 | $46.214 | $42.87 | 7.8% |
| 2023-11-10 | 13 | $57 | $30 | $46.384 | $42.87 | 8.2% |
| 2023-11-14 | 13 | $57 | $32 | $47.769 | $42.87 | 11.43% |
| 2023-12-01 | 13 | $57 | $32 | $47.846 | $42.87 | 11.61% |
| 2023-12-18 | 13 | $57 | $32 | $48 | $42.87 | 11.97% |
| 2023-12-20 | 14 | $57 | $32 | $48 | $42.87 | 11.97% |
| 2023-12-29 | 14 | $57 | $32 | $48.785 | $42.87 | 13.8% |
The Trend in the Analyst Price Target
IMVT's average price target has moved down $9.49 over the prior 36 months.
Over the past 47 weeks, IMVT's average upside potential has been 29.86%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-13 | 9 | 31 | 5.001 | 23.250 | 18.09 | 28.52% |
| 2023-07-18 | 14 | 35 | 5.001 | 27.833 | 24.94 | 11.6% |
| 2023-08-11 | 14 | 35 | 5.001 | 28.500 | 22.47 | 26.84% |
| 2023-12-12 | 14 | 57 | 32.000 | 48.000 | 43.60 | 10.09% |
| 2023-12-13 | 13 | 57 | 32.000 | 48.000 | 43.59 | 10.12% |
IMVT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.07 | 13 | 1 | 0 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 26 weeks, IMVT's average broker recommendation rating improved by 0.22.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, IMMUNOVANT INC's upside potential (average analyst target price relative to current price) is higher than 466.76% of them.
- In the context of all US stocks, IMMUNOVANT INC's variance in analysts' estimates is lower than -4354.9% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, IMMUNOVANT INC's number of analysts covering the stock is greater than 4046% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, IMMUNOVANT INC's average analyst price target is greater than 1948.77% of them.
Stocks similar to IMMUNOVANT INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALLO, KOD, and REPL.
View All Top Stocks by Price Target
Make investment decisions regarding IMVT using the data that counts. Try POWR Ratings for free.